v3.20.2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Consolidated Statements of Operations and Comprehensive Loss    
Sales $ 2,153,354 $ 3,246,038
Cost of Sales 893,374 1,630,166
Gross Margin 1,259,980 1,615,872
Operating expenses    
Sales and marketing 2,172,972 2,339,359
Research and development 3,889,461 3,174,892
General and administrative 4,199,400 3,893,393
Share-based compensation expense (Note 11) 1,781,612 1,347,399
Amortization (Note 4) 277,258 278,997
Depreciation (Note 7) 103,388 69,212
Total operating expenses 12,424,091 11,103,252
Other (income) expenses    
Goodwill impairment 11,222,291 0
Technology and other assets impairment 2,700,540 0
Accretion expense (Note 8) 0 3,266,918
Fair Value Adjustment (Note 8) 0 (337,923)
Gain/Loss on mark to market re-evaluation (Note 10(c)) 0 (2,048,697)
Other expense 181,914 262,596
Other income (100,165) (73,166)
Foreign exchange (152,194) (507)
Total other (income) expenses 13,852,386 1,069,221
Net loss and comprehensive loss for the year $ (25,016,497) $ (10,556,601)
Loss per share - basic and diluted $ (5.61) $ (4.47)
Weighted average number of shares outstanding - basic and diluted 4,455,755 2,363,107

Source